Short Interest in Exicure, Inc. (NASDAQ:XCUR) Declines By 17.3%

Exicure, Inc. (NASDAQ:XCUR) was the target of a significant decrease in short interest during the month of January. As of January 15th, there was short interest totalling 50,600 shares, a decrease of 17.3% from the December 31st total of 61,200 shares. Currently, 21.5% of the shares of the stock are short sold. Based on an average daily volume of 727,200 shares, the days-to-cover ratio is presently 0.1 days.

Exicure Stock Up 3.9 %

Shares of Exicure stock opened at $11.23 on Friday. The business has a fifty day simple moving average of $16.24 and a 200 day simple moving average of $7.01. Exicure has a 12 month low of $1.44 and a 12 month high of $36.00. The stock has a market cap of $29.27 million, a PE ratio of -5.43 and a beta of 3.81.

Exicure Company Profile

Exicure, Inc, an early-stage biotechnology company, develops nucleic acid therapies targeting ribonucleic acid against validated targets. The company's preclinical candidate includes SCN9A that is in preclinical studies for the treatment of chronic pain. It also develops immuno-oncology therapeutics based on its proprietary SNA technology.